Abstract:
본 고안은 어플리케이터를 갖는 마스크 팩에 관한 것으로, 더욱 상세하게는 시트부에 발열부를 설치하고 어플리케이터를 연결하여 시트부의 온도를 올릴 수 있도록 된 마스크 팩에 관한 것이다. 본 고안은 눈, 코 및 입과 대응되는 위치가 개구되도록 형성된 시트부와; 상기 시트부에 설치되며 전기의 인가에 의해 발열되는 발열부와; 상기 발열부에 전기를 인가하는 전원공급수단과 상기 전원공급수단을 제어하는 제어수단으로 이루어진 어플리케이터;를 포함하는 마스크 팩을 제공한다.
Abstract:
PURPOSE: A composition containing Artemisia annua L. extract is provided to promote skin cells and collagen synthesis and to improve anti-aging and anti-wrinkling. CONSTITUTION: A composition for anti-aging contains 0.0001-10 wt% of Artemisia annua L. extract as an active ingredient. The extract is prepared using anhydrous and hydrous low alcohol of 1-4 carbon atoms, acetone, butylenes glycol, ethyl acetate, diethyl acetate, diethyl ether, benzene, chloroform, or hexane. The composition is used for anti-wrinkling and elasticity enhancement.
Abstract:
PURPOSE: A method for visibly measuring skin cell regeneration is provided to observe seed weight and bud length without special equipment. CONSTITUTION: A method visible measuring skin cell regeneration ability comprises: a step of preparing herb material extract; a step of measuring the weight of seeds; a step of the seeds using the extract for germination; a step of measuring the weight of the seeds and the length of the buds; and a step of determining skin regeneration.
Abstract:
PURPOSE: A cosmetic composition for skin whitening is provided to prevent or treat pigmentation such as freckle and melasma and to relieve skin irritation. CONSTITUTION: A cosmetic composition for skin whitening contains Oldenlandia diffusa extract, beta-hydroxylic acid, and Liriope platyphyllla extract as an active ingredient. The Oldenlandia diffusa extract is contained in 0.001-10 weight%. The beta-hydroxylic acid is beta-hydroxybutyric acid, beta-hydroxy beta-methylbutylate, carnitine, 3-hydroxypropionic acid, or salicylic acid. The beta-hydroxylic acid is contains in 0.001-0.5 weight%.
Abstract:
A composition for skin external application is provided to improve the skin wrinkle. A kaempferol-3-O-rutinoside suppresses a collagenase expression and accelerates a production of procollagen. A composition for skin external application for improving skin wrinkle contains the kaempferol-3-O-rutinoside expressed by a chemical formula 1. The composition is used as astringent cosmetic water, lotion, moisturizing cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing foam, cleansing water, pack, powder, body lotion, body cream, body oil, body essence, makeup base, foundation, hair-dye, shampoo, rinse or the body cleansing agent. The kaempferol-3-O-rutinoside is separated from the green tea.
Abstract:
A method for preparing ortho-dihydroxyisoflavones having high antioxidative and skin-whitening effects through the biotransformation system is provided to improve the preparation yield of ortho-dihydroxyisoflavones by using microorganisms. The ortho-dihydroxyisoflavones including 7,8,4݆-trihydroxyisoflavone, 7,6,4݆-trihydroxyisoflavone, 7,3݆,4݆-trihydroxyisoflavone and 7,5,3݆,4݆-tetrahydroxyisoflavone are prepared by biotransforming daidzein and genistein with a microorganism derived from Actinomyces selected from Streptomyces evermitilis, Nocardia farcinica and Streptomyces lincolnesis through site specific hydroxylation at 3݆ site in a batch reactor to which oxygen is supplied.
Abstract:
A pharmaceutical composition comprising compounds capable of increasing expressions of isocitrate dehydrogenase 3alpha(IDH3alpha) and carnitine palmitoyl transferase 1A(CPT1A) by increasing activity of their promoters is provided to reduce synthesis of fatty acid and promote oxidation of fatty acid, so that the composition is useful for treating and preventing lipid metabolism-related diseases. A pharmaceutical composition for treating and preventing lipid metabolism-related diseases comprises compounds represented by the formula(1) in which R1 is adamantly group or phenyl group substituted by H, OH or C1-C5 alkyl, and R2 is CONH or NHCO, and further comprises pharmaceutically acceptable carriers, excipients or diluents selected from lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, crystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil.
Abstract:
A composition for inhibiting sebum secretion and obesity comprising kaempferol is provided to inhibit overproduction of sebum and degrade a neutral fat accumulated in a fat cell, so that the composition is useful for prevention and treatment of diseases caused by overproduction of sebum including acnes, hair loss and seborrheic dermatitis, and obesity. The composition for inhibiting sebum secretion and obesity comprises 0.0001-10 wt.% of kaempferol obtained by degrading kaempferol glycoside with an acid, a base, an enzyme or an enzyme-producing microorganism, wherein the kaempferol glycoside is isolated from a plant, especially green tea; the acid is hydrochloric acid, sulfuric acid or nitric acid; the base is sodium hydroxide or potassium hydroxide; the enzyme is glucosidase, arabinosidase, rhamnosidase, xylosidase, cellulose, hesperidinase, naringinase, glucuronidase, pectinase, galactosidase or amylogucosidase; and the enzyme-producing microorganism is Aspergillus sp., Bacillus sp., Penicillium sp., Rhizopus sp., Rhizomucor sp., Talaromyces sp., Bifidobacterium sp., Mortierella sp., Cryptococcus sp. or Microbacterium sp.